GSK has announced a 50/50 joint venture with ... six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases.

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

India's Intellectual Property Appellate Board (IPAB) has revoked the patent for global pharmaceutical company, GlaxoSmithKline's anti-cancer drug Tykerb. Tykerb (lapatinib) is a dual tyrosine ...

British drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion payment. IDRx develops a treatment for gastrointestinal stromal ...

1961 while making remittance of Rs 3,045 crore for payment towards acquisition of India Health Food Drink (HFD) intellectual property rights (IPR) from GlaxoSmithKline ‘GSK’ Group entities.

New Delhi, Mar 3 () Drug firm GlaxoSmithKline Pharmaceuticals on Tuesday said it has appointed Sridhar Venkatesh as managing director & vice president of GSK India, effective April 1, 2020.

They have two manufacturing units in India, located at Nashik and Thane. Also, they have a clinical development centre in Bangalore. GlaxoSmithKline Pharma Limited was incorporated in November 13 ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

Drugmaker GSK said, a stamp has been released by India Post to commemorate its 100 years in India. The ₹5 denomination stamp and “special cover” will be available at 1100 post offices across ...

GlaxoSmithKline Pharmaceuticals Ltd. (‘GSK India’) announces completion of its transaction with Novartis Healthcare Pvt. Ltd. ... GSK Pharma's Bengaluru facility to be operational by 2017 The ...

Pricing regulations and a complex approval process are among the regulatory challenges pharma firms have faced in India. GlaxoSmithkline India’s profits plunged by over 70% in the third quarter ...